Ligufalimab (Anti-CD47)
Ligufalimab (Anti-CD47) is a humanized immunoglobulin G4 (IgG4) monoclonal antibody targeting leukocyte surface antigen CD47, with potential immune checkpoint inhibitory and antineoplastic activities. MW : 144.58 KD.
Supplier | Selleck Chemicals |
---|---|
Product # | A2825 |
Sku # | A2825-1mg*5 |
Pricing | 1mg*5, $1690.00 |